Stephanie Assuras, PhD
Assistant Professor of Neuropsychology
Division of Cognitive Neuroscience
710 West 168th Street
New York, NY 10032
Telephone (for appointments): 646-426-3876
Insurance: 1199, Aetna, CIGNA, Empire BC/BS, Fidelis, Healthplus/Amerigroup, Multi-Plan, Oxford, United Healthcare, Medicare
*Please verify insurance participation with the physician's office when making an appointment.
» Clinical Neuropsychology Service
» Department of Neurology
Dr. Stephanie Assuras is an assistant professor of neuropsychology in the Clinical Neuropsychology Service within the Division of Cognitive Neuroscience. After completing her doctoral training in clinical neuropsychology at the Graduate Center of the City University of New York, she completed an internship at the University of Chicago Medical Center and advanced training in a clinical neuropsychology postdoctoral fellowship at Harvard Medical School/Massachusetts General Hospital/Brigham and Women's Hospital, where she received training in the assessment of both adults and children. Her primary clinical and research activities have focused on differential diagnosis of neurodegenerative diseases such Alzheimer's disease, Parkinson's disease and other movement disorders, as well as prognostication of shunt response in normal pressure hydrocephalus via cognitive assessment and cerebrospinal fluid biomarkers. In addition to her focus on aging and dementia, she has expertise in concussion assessment of both adults and adolescents, and cognitive behavioral interventions for persisting post-concussion syndrome.
Primary research activities have focused on aging and neurodegenerative diseases, including the differential role of dopamine in emotional attention and memory in Parkinson's disease, and assessment of cognitive functioning and prediction of shunt response in normal pressure hydrocephalus. In addition to neuropsychological research, Dr. Assuras continues to collaborate on studies evaluating the use of cerebrospinal fluid biomarkers for the differential diagnosis of normal pressure hydrocephalus and Alzheimer's disease using proteomics.